NCT02361125 2022-01-04
Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate
M.D. Anderson Cancer Center
Phase 1 Completed
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.